PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,410 | +153.8% | 1,444,000 | +84.5% | 2.53% | +150.0% |
| Q4 2022 | $15,131 | -99.9% | 782,788 | 0.0% | 1.01% | -11.5% |
| Q3 2022 | $16,352,000 | +323.2% | 782,788 | +62.3% | 1.14% | +291.4% |
| Q2 2022 | $3,864,000 | +14.3% | 482,413 | 0.0% | 0.29% | +12.3% |
| Q1 2022 | $3,382,000 | -48.1% | 482,413 | 0.0% | 0.26% | -32.8% |
| Q4 2021 | $6,513,000 | -20.0% | 482,413 | 0.0% | 0.39% | +16.9% |
| Q3 2021 | $8,143,000 | -42.0% | 482,413 | 0.0% | 0.33% | -30.6% |
| Q2 2021 | $14,048,000 | -41.6% | 482,413 | -21.1% | 0.48% | -11.0% |
| Q1 2021 | $24,047,000 | +73.1% | 611,409 | 0.0% | 0.54% | +61.9% |
| Q4 2020 | $13,891,000 | +2.4% | 611,409 | 0.0% | 0.33% | -36.6% |
| Q3 2020 | $13,571,000 | -27.9% | 611,409 | 0.0% | 0.52% | -27.3% |
| Q2 2020 | $18,812,000 | – | 611,409 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |